Vivos Therapeutics, Inc. (VVOS) stock
VVOSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$0.10+0.00 (+2.40%)
Close on Nov 13, 2026Market cap $1.97MP/E –Yield –
Vivos Therapeutics statistics
84 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- –
- Last ex-dividend date
- No dividends
- Fundamentals through
- Jun 30, 2026
- Share price as of
- Nov 13, 2026
Valuation ratiosIndustry
Enterprise valuationIndustry
- EV / Sales
- 0.39
- 2.60
Share statisticsIndustry
- Shares Change (YoY)
- 76.7%
- 3.32%
- Shares Change (QoQ)
- 7.75%
- 0.20%
- Float
- 14M
- 37M
- Shares Held by Insiders
- 30.4%
- 10.5%
- Shares Held by Institutions
- 2.64%
- 60.5%
Short sellingIndustry
- Short Interest
- 3M
- –
- Short Interest Change
- 30.1%
- -2.57%
- Short % of Float
- 21.9%
- 5.11%
- Short % of Shares Outstanding
- 15.3%
- 3.98%
- Days to Cover
- 1.00
- 3.94
Stock price statisticsIndustry
- 52-Week High
- $2.69
- –
- 52-Week Low
- $0.09
- –
- 20-Day Moving Average
- $0.11
- –
- 50-Day Moving Average
- $0.14
- –
- 200-Day Moving Average
- $0.66
- –
- Average True Range (14)
- $0.01
- –
- Price Change (1 Week)
- 4.59%
- 0.99%
- Price Change (1 Month)
- -31.4%
- -3.52%
- Price Change (3 Months)
- -67.5%
- -7.86%
- Price Change (6 Months)
- -84.7%
- -1.12%
- Price Change (YTD)
- -95.2%
- -2.92%
- Price Change (1 Year)
- -96.1%
- -1.37%
- Price Change (3 Years)
- -97.4%
- 3.24%
- Price Change (5 Years)
- -99.9%
- -50.4%
- Average Volume (10 Days)
- 612,103
- –
- Average Volume (20 Days)
- 7M
- –
- Average Volume (90 Days)
- 11M
- –
- Relative Volume
- 0.07
- 0.76
- Relative Strength Index (14)
- 33.2
- 46.7
- Volatility (1 Year)
- 95.8%
- 64.2%
- Beta (5 Years)
- 1.44
- 1.04
MarginsIndustry
- Pretax Margin
- -122.6%
- -2.32%
- EBITDA Margin
- -99.4%
- -2.52%
- FCF Margin
- -91.0%
- 0.65%
Returns on capitalIndustry
- Return on Equity (ROE)
- -6629.4%
- -17.3%
- Return on Assets (ROA)
- -101.5%
- -12.3%
- Return on Invested Capital (ROIC)
- -334.7%
- -2.83%
- Return on Capital Employed (ROCE)
- -600.7%
- -8.13%
Financial positionIndustry
- Current Ratio
- 0.21
- 2.49
- Quick Ratio
- 0.16
- 1.53
- Interest Coverage
- -6.44
- -1.63
GrowthIndustry
- Revenue Growth (YoY)
- 45.2%
- 9.42%
- Revenue Growth (3Y CAGR)
- 2.87%
- 7.08%
- Revenue Growth (5Y CAGR)
- 5.95%
- 11.8%
EfficiencyIndustry
- Asset Turnover
- 0.83
- 0.59
- Revenue Per Employee
- $77.99K
- $331.99K
- Profits Per Employee
- -$94.99K
- -$46.47K
- Employee Count
- 268
- 193
- WACC
- 12.0%
- 9.91%
Income statement (TTM)Industry
- Pretax Income
- -$25.63M
- -$1.83M
Balance sheetIndustry
- Net Cash (Debt)
- -$6.36M
- $3.95M
- Net Cash Per Share
- -$0.32
- $0.26
- Equity (Book Value)
- -$3.82M
- $63.80M
- Book Value Per Share
- -$0.19
- $3.26
- Tangible Book Value
- -$16.03M
- $11.61M
- Working Capital
- -$16.18M
- $57.32M
Cash flow (TTM)Industry
- Capital Expenditures
- -$1.88M
- -$3.94M
- FCF Per Share
- -$0.95
- -$0.00
Dividends and yieldsIndustry
- Earnings Yield
- -1291.2%
- -4.76%
- FCF Yield
- -964.4%
- 0.28%
- Buyback Yield
- -297.3%
- 0.80%
- Shareholder Yield
- -297.3%
- 1.12%
Taxes and interestIndustry
- Interest Expense
- $3.50M
- $5.40M
Scores and fair valueIndustry
- Altman Z-Score
- -11.01
- 2.47
- Piotroski F-Score
- 3
- 5
- Beneish M-Score
- -1.30
- -2.64
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | VVOS | S&P 500 | Difference | VVOS per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -30.8% | -3.0% | −27.8 pts | ||
| 3 months | -67.9% | -2.8% | −65.1 pts | ||
| Year to date | -95.2% | +11.5% | −106.7 pts | ||
| 1 year | -96.0% | +13.5% | −109.4 pts | ||
| 3 years | -97.1% | +77.7% | −174.8 pts | -69.3% | +21.1% |
| 5 years | -99.9% | +72.6% | −172.5 pts | -74.9% | +11.5% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
3M VVOS shares were sold short on Oct 30, 2026, up 30.1% from the previous report, or 21.90% of the shares available to trade. At recent volumes it would take 1.0 days to buy them back. Over the last 20 sessions, 30.5% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 3,068,217 | +30.1% | 12,307,775 | 1.0 |
| Oct 15, 2026 | 2,358,382 | -17.7% | 2,426,297 | 1.0 |
| Sep 30, 2026 | 2,864,201 | +76.1% | 8,031,092 | 1.0 |
| Sep 15, 2026 | 1,626,351 | -35.0% | 9,032,033 | 1.0 |
| Aug 31, 2026 | 2,503,479 | +100.4% | 49,532,777 | 1.0 |
| Aug 14, 2026 | 1,249,260 | +4.0% | 5,552,219 | 1.0 |
| Jul 31, 2026 | 1,201,767 | -0.2% | 154,184 | 7.8 |
| Jul 15, 2026 | 1,203,866 | +2.5% | 195,315 | 6.2 |
| Jun 30, 2026 | 1,174,295 | +23.9% | 1,685,117 | 1.0 |
| Jun 15, 2026 | 947,441 | +20.4% | 7,024,292 | 1.0 |
| May 29, 2026 | 786,598 | -19.6% | 160,238 | 4.9 |
| May 15, 2026 | 978,065 | +36.6% | 151,802 | 6.4 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?